Literature DB >> 23793734

[Intraoperative inhibition of fibrosis in modern trabeculectomy].

A Koutsonas, A Remky, N Plange.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23793734     DOI： 10.1007/s00347-013-2899-6

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  7 in total

1.  Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial.

Authors:  K Singh; K Mehta; N M Shaikh; J C Tsai; M R Moster; D L Budenz; D S Greenfield; P P Chen; J S Cohen; G S Baerveldt; S Shaikh
Journal:  Ophthalmology       Date:  2000-12       Impact factor: 12.079

2.  Standardization of the dose of intraoperative mitomycin C in trabeculectomy.

Authors:  G Krommes; W Lieb; F Grehn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-07       Impact factor: 3.117

3.  [White coloration after spontaneous macular hemorrhage].

Authors:  A Koutsonas; N Plange; G Rössler; B Mazinani
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

4.  [Modern filtration surgery. An update].

Authors:  T Klink; F Grehn
Journal:  Ophthalmologe       Date:  2013-04       Impact factor: 1.059

5.  A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy.

Authors:  Darrell WuDunn; Louis B Cantor; Angelita M Palanca-Capistrano; Joni Hoop; Nishat P Alvi; Charles Finley; Vipul Lakhani; Alan Burnstein; Stephenie L Knotts
Journal:  Am J Ophthalmol       Date:  2002-10       Impact factor: 5.258

6.  Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery.

Authors:  Angelita M Palanca-Capistrano; Jason Hall; Louis B Cantor; Linda Morgan; Joni Hoop; Darrell WuDunn
Journal:  Ophthalmology       Date:  2008-10-18       Impact factor: 12.079

7.  Large-area versus small-area application of mitomycin C during trabeculectomy.

Authors:  Juliane Matlach; Ermioni Panidou; Franz Grehn; Thomas Klink
Journal:  Eur J Ophthalmol       Date:  2013-04-18       Impact factor: 2.597
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.